Vadim Z Lankin Selected Research

carcinine

4/2015	The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
12/2013	Diabetes mellitus: novel insights, analysis and interpretation of pathophysiology and complications management with imidazole-containing peptidomimetic antioxidants.
10/2012	Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vadim Z Lankin Research Topics

Disease

9	Atherosclerosis 12/2022 - 07/2003
3	Diabetes Mellitus 04/2015 - 12/2013
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 12/2013
2	Hyperglycemia 01/2017 - 04/2015
2	Diabetes Complications 04/2015 - 10/2012
1	Coronary Disease (Coronary Heart Disease) 06/2023
1	Heart Diseases (Heart Disease) 12/2022
1	Hyperlipidemias (Hyperlipidemia) 12/2021
1	Radiation Injuries (Radiation Sickness) 11/2021
1	Necrosis 04/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2021
1	Infarction (Infarctions) 04/2021
1	Ischemia 04/2021
1	Myocardial Reperfusion Injury 04/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2021
1	Arteriosclerosis 01/2017
1	Dyslipidemias (Dyslipidemia) 04/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2015
1	Diabetic Neuropathies (Diabetic Neuropathy) 04/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2013
1	Skin Diseases (Skin Disease) 10/2012

Drug/Important Bio-Agent (IBA)

8	Free RadicalsIBA 11/2022 - 07/2003
6	AntioxidantsIBA 11/2021 - 07/2003
5	oxidized low density lipoproteinIBA 06/2023 - 07/2003
4	Malondialdehyde (Propanedial)IBA 12/2022 - 11/2014
3	EnzymesIBA 04/2021 - 04/2015
3	LDL Lipoproteins (beta Lipoproteins)IBA 04/2021 - 07/2003
3	CarnosineIBA 04/2015 - 10/2012
3	carcinineIBA 04/2015 - 10/2012
2	Peptides (Polypeptides)IBA 04/2021 - 04/2015
2	Glyoxal (Ethanedial)IBA 01/2017 - 11/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 11/2014
2	imidazoleIBA 04/2015 - 12/2013
1	ApoproteinsIBA 08/2022
1	Lipoproteins (Lipoprotein)IBA 12/2021
1	Nonesterified Fatty Acids (NEFA)IBA 12/2021
1	Triglycerides (Triacylglycerol)IBA 12/2021
1	Superoxide Dismutase-1IBA 04/2021
1	CatalaseIBA 04/2021
1	Glutathione PeroxidaseIBA 04/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2021
1	GalaninIBA 04/2021
1	Galanin Receptors (Galanin Receptor)IBA 04/2021
1	MB Form Creatine KinaseIBA 04/2021
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2017
1	Advanced Glycation End ProductsIBA 04/2015
1	polyolIBA 04/2015
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 04/2015
1	Glutathione (Reduced Glutathione)IBA 04/2015
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2014
1	PeptidomimeticsIBA 12/2013
1	Insulin (Novolin)FDA Link 12/2013
1	ProdrugsIBA 12/2013
1	N-acetylcarnosineIBA 12/2013
1	Vitamin E FDA LinkGeneric 07/2003
1	Pravastatin (Pravachol)FDA LinkGeneric 07/2003
1	Probucol (Lorelco)FDA Link 07/2003
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2003
1	cerivastatin (Kazak)FDA Link 07/2003
1	coenzyme Q10 (CoQ10)IBA 07/2003

Therapy/Procedure

1	Intravenous Administration 04/2021
1	Therapeutics 10/2012